Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
1.270
-0.010 (-0.78%)
At close: Sep 5, 2025, 4:00 PM
1.280
+0.010 (0.79%)
Pre-market: Sep 8, 2025, 8:35 AM EDT
Opus Genetics Employees
Opus Genetics had 18 employees as of December 31, 2024. The number of employees increased by 4 or 28.57% compared to the previous year.
Employees
18
Change (1Y)
4
Growth (1Y)
28.57%
Revenue / Employee
$856,722
Profits / Employee
-$3,237,500
Market Cap
80.07M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18 | 4 | 28.57% |
| Dec 31, 2023 | 14 | 5 | 55.56% |
| Dec 31, 2022 | 9 | 1 | 12.50% |
| Dec 31, 2021 | 8 | 3 | 60.00% |
| Dec 31, 2020 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IRD News
- 4 days ago - Opus Genetics Doses First Patient in Pivotal LYNX-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions - GlobeNewsWire
- 5 days ago - Opus Genetics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 6 days ago - Opus Genetics Appoints Rob Gagnon as Chief Financial Officer - GlobeNewsWire
- 12 days ago - Opus Genetics Inherited Retinal Disease Programs Featured at Medical and Industry Conferences in September - GlobeNewsWire
- 21 days ago - Opus Genetics Announces FDA Clearance of IND Application for Gene Therapy Candidate OPGx-BEST1 - GlobeNewsWire
- 25 days ago - Opus Genetics Announces Financial Results for Second Quarter 2025 and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - Opus Genetics to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - GlobeNewsWire
- 6 weeks ago - Opus Genetics and the Global RDH12 Alliance Partner to Advance RDH12 Gene Therapy for Inherited Childhood Blindness - GlobeNewsWire